GRIFOLS | GRF - Vermögenswerte





Vermögenswerte Veränderung Datum
Alcon AG USD 31.62B 64M 2026-03
Almirall EUR 2.34B 29.21M 2025-12
Amadeus IT EUR 11.43B 44.1M 2026-03
Amarin USD 645.76M 25.01M 2026-03
argenx SE USD 8.68B 1.51B 2025-12
AstraZeneca USD 114.02B 59M 2026-03
Bayer EUR 107.94B 3.4B 2026-03
Cie Automotive EUR 5.68B 97.53M 2025-12
Demant DKK 39.07B 6.43B 2025-12
Ence Energia y Celulosa EUR 1.65B 9.23M 2026-03
Essilor EUR 63.9B 1.97B 2025-12
Ferrovial EUR 27.42B 857M 2025-12
Fresenius EUR 41.4B 1.07B 2025-12
Fresenius Medical Care EUR 31.47B 465.26M 2026-03
Genmab DKK 12.87B 5.85B 2025-12
GlaxoSmithKline GBP 62.87B 1.75B 2026-03
GRIFOLS EUR 20.08B 366M 2026-03
Hikma Pharmaceutical USD 5.67B 117M 2025-12
Inditex EUR 36.49B 851M 2026-03
Lakefront Biotherapeutics EUR 3.37B 34.09M 2026-03
Merck EUR 53.07B 1.54B 2026-03
Novartis USD 118.53B 7.58B 2026-03
Philips EUR 27.27B 322M 2026-03
Roche Holding CHF 100.7B 5.94B 2025-12
Sanofi EUR 128.02B 1.22B 2026-03
Smith & Nephew USD 10.69B 150M 2025-12
UCB EUR 18.16B 971M 2025-12
Viscofan EUR 1.52B 74.13M 2026-03